Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for Neural Conduction in Optic Nerve Diseases
NCT00404729Phase 4Completed
- Sponsor
- Fondazione G.B. Bietti-IRCCS
- Start
- Feb 2005
- Primary completion
- Feb 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citicoline in open-angle glaucoma (OAG), non-arteritic anterior ischemic optic neuropathy (NAION), sponsored by Fondazione G.B. Bietti-IRCCS. Started Feb 2005; status: completed.
02
Drugs
citicoline
03
Conditions
open-angle glaucoma (OAG)non-arteritic anterior ischemic optic neuropathy (NAION)
Beyond the preview
Go deeper on NCT00404729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00404729.